• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

21
9
7
6
3

COUNTRY

3
2
2
1
1

CATEGORIES

  • 9
  • 7
  • 6
  • 5
  • 5
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
1
5
36

PUBLISHED

4
7
9
36

PRODUCT TYPE

35
1

Search "Respiratory Diseases: Current and Future Therapeutic Approaches and Market Opportunities" returned 36 results.

PRODUCT TITLE
Pediatric Drugs and Vaccines - Global Strategic Business Report Pediatric Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pediatric Drugs and Vaccines - Global Strategic Business Report

This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective...

September 2014
FROM
Nitric Oxide - Therapeutics, Markets and Companies Nitric Oxide - Therapeutics, Markets and Companies - Product Thumbnail Image

Nitric Oxide - Therapeutics, Markets and Companies

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based...

October 2014
FROM
Antiviral Therapeutics - Technologies, Markets and Companies Antiviral Therapeutics - Technologies, Markets and Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

September 2014
FROM
The Future of RNAi Therapeutics: Drug Pipelines and Prospects The Future of RNAi Therapeutics: Drug Pipelines and Prospects - Product Thumbnail Image

The Future of RNAi Therapeutics: Drug Pipelines and Prospects

"The total RNAi therapy market is estimated to value $580m by 2012 This forecast is based upon current treatments, levels of market satisfaction and five new Phase II/III RNAi agents profiled in this...

September 2008
FROM

Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Amyloidosis Therapeutics - Pipeline...

February 2012
FROM

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022 Summary Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory...

April 2013
FROM
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities - Product Thumbnail Image

Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities

This cutting edge & insightful report can be used to interpret & assess the potential of RNAi-based medicines It provides opinions & market projections to: - assess the commercial potential of RNAi-based...

July 2009
Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships - Product Thumbnail Image

Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships

A major new 3-volume report from Espicom featuring: - An examination of trends and advances in the three major drug delivery sectors - Unique sales forecasts to 2020 for key products - Critical analyses...

September 2011
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

October 2014
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

October 2014
FROM

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick,...

April 2013
FROM
Molecular Diagnostics - Technologies, Markets and Companies Molecular Diagnostics - Technologies, Markets and Companies - Product Thumbnail Image

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

October 2014
FROM
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011 Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011 - Product Thumbnail Image

Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011

This report includes details on 408 emerging medical technology companies that: have presented at a 2011 LSI Emerging Medical Technologies Spotlight meeting or have been identified by LSI's in-house...

December 2011
FROM
2011 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 2011 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

2011 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 408 emerging medical technology companies that: have presented at a 2011 LSI Emerging Medical Technologies Spotlight meeting or have been identified by LSI's in-house...

December 2011
FROM
Future Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies Future Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies - Product Thumbnail Image

Future Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies

The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century Among the main...

November 2011
FROM

Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers

Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial Analysis of the Top Performers Summary Our “Pharmaceutical Leaders 2012 - Key Trends, Emerging Strategies and Financial...

July 2012
FROM
The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics - Product Thumbnail Image

The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics

While the human genome project has provided vast amounts of sequence information, the in vivo functional analysis of thousands of genes has presented a significant challenge to researchers and to pharmaceutical...

May 2005
FROM
2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies 2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies - Product Thumbnail Image

2012 France Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies

This report presents a comprehensive analysis of the French infectious disease testing market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory,...

April 2012
FROM
2012 UK Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies 2012 UK Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies - Product Thumbnail Image

2012 UK Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies

This report presents a comprehensive analysis of the UK infectious disease testing market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic,...

April 2012
FROM
2012 Japan Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies 2012 Japan Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies - Product Thumbnail Image

2012 Japan Infectious Disease Testing Market Outlook: Growth Opportunities and Strategies

This report presents a comprehensive analysis of the Japanese infectious disease testing market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic,...

April 2012
FROM
Loading Indicator

Our Clients

Our clients' logos